Dexcom (DXCM) EV to EBIT (2010 - 2026)

Dexcom (DXCM) has reported EV to EBIT for 17 consecutive years, with 73.74 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBIT fell 49.92% year-over-year to 73.74 in Q2 2026; TTM through Jun 2026 was 20.6, a 54.77% decrease from a year earlier, with the FY2025 full-year figure at 25.82, down 44.29% from the prior year.
• EV to EBIT was 73.74 for Q2 2026 at Dexcom, down from 85.47 in the prior quarter.
• Over five years, EV to EBIT peaked at 1150.12 in Q1 2022 and troughed at 72.88 in Q4 2025.
• A 5-year average of 299.12 and a median of 187.43 in 2025 frame the typical range for EV to EBIT.
• The widest YoY moves for EV to EBIT: up 64.35% in 2022, down 99.6% in 2022.
• Over 5 years, EV to EBIT stood at 329.25 in 2022, then tumbled by 36.85% to 207.93 in 2023, then decreased by 29.21% to 147.2 in 2024, then tumbled by 50.49% to 72.88 in 2025, then rose by 1.18% to 73.74 in 2026.
• The last three EV to EBIT figures came in at 73.74 (Q2 2026), 85.47 (Q1 2026), and 72.88 (Q4 2025), per Business Quant data.